Predictive Biosciences to Present at Key Scientific Conferences

Published: Feb 13, 2013

Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the company will present data on the latest developments related to its CertNDxTM Bladder Cancer Assays at two upcoming scientific conferences, the Molecular Med Tri-Con 2013 and ASCO’s 2013 Genitourinary Cancers Symposium.

Back to news